Projecting future drug expenditures—2005

Hoffman, James M.; Shah, Nilay D.; Vermeulen, Lee C.; Hunkler, Robert J.; Hontz, Karrie M.

doi:10.1093/ajhp/62.2.149

Cited by 33 publications

(14 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10 In our 2005 drug expenditures forecast, we predicted a growth rate of 6-9% for hospital drug expenditures, 12-15% for clinicadministered drug expenditures, and 10-12% for outpatient drug expenditures. 11 During the first nine months of 2005, the growth rate for hospital drug expenditures was 5.6%, which was similar to our projected rate of growth. Volume and drug mix accounted for 2% of the growth, new drugs accounted for 1%, and price inflation accounted for 2% of the growth in hospital drug expenditures in 2005.…”

supporting

confidence: 84%

Projecting future drug expenditures—2006

Hoffman

Shah

Vermeulen

et al. 2006

American Journal of Health-System Pharmacy

Self Cite

View full text Add to dashboard Cite

Forecasting and managing rising drug expenditures remains a challenge. Pharmacy managers must remain vigilant in monitoring drug costs in their health system and take a proactive role in pursuing efficient drug utilization. The dynamic health policy environment further complicates drug budgeting and must be considered, especially in integrated health systems responsible for managing inpatient, outpatient, and clinic drug costs. The comparison of health-system-specific data and trends with the national information presented in this article may provide a useful context when presenting institutional drug costs to senior management.

show abstract

supporting

confidence: 84%

Projecting future drug expenditures—2006

Hoffman

Shah

Vermeulen

et al. 2006

American Journal of Health-System Pharmacy

Self Cite

View full text Add to dashboard Cite

show abstract

“…3 Instead, in addition to the external trends relevant to drug expenditures described in this article, local data must be carefully and systematically incorporated into an organization's own drug expenditure forecast. 60,61 Conclusion…”

Section: Manufacturermentioning

confidence: 99%

National trends in prescription drug expenditures and projections for 2015

Schumock

Suda

et al. 2015

American Journal of Health-System Pharmacy

Self Cite

View full text Add to dashboard Cite

show abstract

“…Finally, biological therapies, such as somatropin (Genotropin, Pfizer), represented the greatest drug expense. 19 Americans also spend a tremendous amount of money on nonprescription medications. In 2004, $15.1 billion was spent on nonprescription medications in the United States (this excludes pharmacy sales figures from Wal-Mart, the nation's largest retailer, which were not made available).…”

Section: Special Feature Work Force In Pharmacy E31mentioning

confidence: 99%